In this review, we discuss the canonical roles and stimuli of GC-C, extraintestinal effects, and how changes in GC-C-mediated signaling underpin colorectal cancer (CRC) and inflammatory bowel disease (IBD) (Figure 1). This evidence concerns the gene GUCY2C and irritable bowel syndrome.